Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
Platinum-based chemotherapy agents initially transformed cancer treatment. However their effectiveness peaked as combined regimes showed little additional benefit in trials. New research frontiers developed with the discovery that conventional chemotherapy can induce immunological cell death by recr...
Saved in:
Main Author: | Rao Khalid Mehmood (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monoclonal Antibodies for Treatment of COVID-19: An Updated Review of Current Evidence
by: Saurabh Nimesh, et al.
Published: (2024) -
Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma
by: J. Milburn Jessup, et al.
Published: (2020) -
Monoclonal Antibodies
Published: (2021) -
Monoclonal Antibodies
by: Christian Klein (Ed.)
Published: (2018) -
Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions
by: Valeria Ferla, et al.
Published: (2024)